MIRIKIZUMAB Pharmacologic Class Indexing
- Class set ID
- 36f9dbad-9e90-44a7-900d-c16bd5dd9ffe
- Version
- 1
- Effective date
- 20231102
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use OMVOH safely and effectively. See full prescribing information for OMVOH. OMVOH (mirikizumab-mrkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2023 | Eli Lilly and Company | 20251104 | 18 |